Navigation Links
Myriant Produces Succinic Acid and Lactic Acid From Non-Food Cellulosic Feedstocks

QUINCY, Mass., Oct. 5, 2011 /PRNewswire/ -- Myriant Corporation today announced the successful development of its proprietary process for producing targeted bio-based chemicals, including succinic acid and both L(+) and D(-) lactic acid, from non-food, renewable, cellulosic feedstocks.


"Today's announcement is a significant step forward in our ability to continue driving the advancement and global use of cellulosic materials as the foundation for manufacturing of bio-based chemicals," said Stephen Gatto, CEO and Chairman of Myriant Corporation.  "We recognized early on that these renewable feedstocks were a critical component of the technology platform for our succinic acid and lactic acid programs."

This development is an integral part of Myriant's manufacturing and commercialization strategy. "We believe that Myriant's ability to use non-food cellulosic feedstocks, as opposed to traditional food-based or petroleum-based feedstocks, gives it a critical global competitive advantage," said Mr. Gatto.  The ability to take advantage of these abundant low-cost feedstocks allows Myriant to roll out its succinic acid and lactic acid manufacturing platforms throughout the world, without being restricted to scarce availability and expensive food-based feedstocks.  Furthermore, it provides stable feedstock pricing, which will enable Myriant to offer its customers long term price stability.

In 2009, Myriant was awarded $50 million from U.S. Department of Energy, which supports the company's construction of its 30 million pound succinic acid facility in Lake Providence, Louisiana and the commercialization of its cellulosic succinic acid program. "The results achieved today testify to Myriant's continued leadership in the manufacture of cost-effective bio-based chemical intermediates and builds off of Myriant's core competency in industrial bio-technology," added Mr. Gatto.

The use of cellulosic biomass, an abundant global resource, will provide a renewable feedstock manufacturing base for many next-generation, bio-derived products. The success of the biochemical industry is highly dependent on a cost-effective, high-quality, and functional supply of sustainable biomass feedstocks.

About Myriant

Myriant utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable commercialization of high-value bio-based chemicals. In December 2010, Myriant broke ground on its 30 million pound commercial succinic acid facility in Lake Providence, Louisiana. The company's D(-) lactic acid started production at commercial scale in June 2008 for use in polylactic acid. Myriant has announced agreements with Uhde GmbH for engineering, Davy Process Technology for the integration of Myriant's succinic acid process with the Davy butanediol process for the production of bio-based butanediol, and PTT Chemical for the commercialization of Myriant's technology in South East Asia.

Myriant is headquartered in Quincy, Massachusetts. Details are available at

Samuel G. McConnell, Sr.VP, Corporate Development
Telephone:  (617) 657-5207

SOURCE Myriant Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Myriant Technologies, Inc. Announces J. Brian Ferguson to Join Advisory Board
2. Myriant Technologies, Inc. Announces US$60 Million Strategic Equity Investment From PTT Chemical Group
3. Gov. Jindal Announces Myriant Technologies to Begin Construction of New, Sustainable Specialty Chemical Plant in Lake Providence
4. Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project
5. Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants
6. Myriant Technologies LLC Announces Appointment of Science Advisory Board Members
7. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
8. Pixantrone in Combination with Fludarabine, Dexamethasone and Rituximab Produces High Rates of Complete Remissions in Patients with Relapsed or Refractory Indolent Non-Hodgkins Lymphoma
9. Optical microscope without lenses produces high-resolution 3-D images on a chip
10. Templated growth technique produces graphene nanoribbons with metallic properties
11. Nanotech milling produces dramatic increase in thermoelectric performance of bulk semiconductor
Post Your Comments:
(Date:11/26/2015)... CHESHAM , England , November 26, ... Lightpoint Medical, an innovative medical device company specializing in ... Euro grant from the European Commission as part of the ... enabling the company to carry out a large-scale clinical trial ... -->      (Logo: , ...
(Date:11/25/2015)... -- PharmAthene, Inc. (NYSE MKT: PIP) announced  today that its ... (Rights Plan) in an effort to preserve the value ... 382 of the Internal Revenue Code (Code). ... its NOLs could be substantially limited if the Company ... of the Code. In general, an ownership change occurs ...
(Date:11/25/2015)... Studies reveal the differences in species of ... way for more effective treatment for one of the most ... --> --> Gum disease is ... yet relatively little was understood about the bacteria associated with ... by researchers from the WALTHAM Centre for Pet Nutrition together ...
(Date:11/25/2015)... 2015  Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) ... CEO of Neurocrine Biosciences, will be presenting at the ... New York . .   ... 5 minutes prior to the presentation to download or ... will be available on the website approximately one hour ...
Breaking Biology Technology:
(Date:11/12/2015)... 12, 2015  A golden retriever that stayed healthy ... (DMD) has provided a new lead for treating this ... Broad Institute of MIT and Harvard and the University ... Cell, pinpoints a protective gene ... disease,s effects. The Boston Children,s lab of Lou ...
(Date:11/11/2015)... MedNet Solutions , an innovative SaaS-based eClinical technology company that ... announce that it will be a Sponsor of the ... held November 17-19 in Hamburg , Germany.  ... iMedNet , MedNet,s easy-to-use, proven and affordable eClinical ... able to deliver time and cost savings of up to ...
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
Breaking Biology News(10 mins):